Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000188:drug therapy; D004932:Esophageal and Gastric Varices / Q000628:therapy; D006242:Haptoglobins / Q000627:therapeutic use*; D006801:Humans; D009829:Oleic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000009:adverse effects* / Q000627:therapeutic use
D006242:Haptoglobins; D009829:Oleic Acids; D012597:Sclerosing Solutions; C033343:ethanolamine oleate